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Abstract: The aim of the study was to examine antidotal potency of trimedoxime in mice poisoned with three direct
dimethoxy-substituted organophosphorus inhibitors. In order to assess the protective efficacy of trimedoxime against
dichlorvos, heptenophos or monocrotophos, median effective doses and efficacy half-times were calculated. Trimedoxime
(24 mg/kg intravenously) was injected 5 min. before 1.3 LD50 intravenously of poisons. Activities of brain, diaphragmal
and erythrocyte acetylcholinesterase, as well as of plasma carboxylesterases were determined at different time intervals
(10, 40 and 60 min.) after administration of the antidotes. Protective effect of trimedoxime decreased according to the
following order: monocrotophos  heptenophos  dichlorvos. Administration of the oxime produced a significant reacti-
vation of central and peripheral acetylcholinesterase inhibited with dichlorvos and heptenophos, with the exception of
erythrocyte acetylcholinesterase inhibited by heptenophos. Surprisingly, trimedoxime did not induce reactivation of mon-
ocrotophos-inhibited acetylcholinesterase in any of the tissues tested. These organophosphorus compounds produced a
significant inhibition of plasma carboxylesterase activity, while administration of trimedoxime led to regeneration of the
enzyme activity. The same dose of trimedoxime assured survival of experimental animals poisoned by all three organ-
ophosphorus compounds, although the biochemical findings were quite different.
The primary molecular mechanism of action of the organ-
ophosphorus compounds is inhibition of acetylcholine-
sterase (AChE, EC 3.1.1.7.) (Koelle 1975). Inhibition of
AChE results in accumulation of acetylcholine (ACh) at the
synaptic cleft of the cholinergic neurones, leading to oversti-
mulation of cholinergic receptors. In addition to the inhi-
bition of AChE, organophosphorus compounds clearly
have a potential to interact with other esterases such as car-
boxylesterases (EC 3.1.1.1.). Carboxylesterases play an im-
portant role in the detoxification of organophosphorus
compounds via hydrolysis of ester bond in these compounds
and binding of the compounds at the active site of carboxyl-
esterases that reduces the free concentration of organophos-
phate potentially available to inhibit acetylcholinesterase
(Jokanovic´ et al. 1996; Sogorb & Vilanova 2002).
Together with atropine pyridinium oximes (pralidoxime,
trimedoxime, obidoxime, HI-6, HLö-7) represent the most
important component of the specific therapy used against
organophosphate poisoning (Bismuth et al. 1992; Karallied-
de & Szinicz 2001). Since the resulting inhibited AChE is
generally considered very stable and is only slowly reactiv-
ated by spontaneous hydrolysis of the phosphate ester, the
essential role of the oximes is their ability to reactivate in-
hibited AChE (Worek et al. 1997; Thiermann et al. 1999).
Other effects attributed to the oximes (in very high doses)
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are: weak ability to inhibit cholinesterase, direct reaction
with organophosphates, anticholinergic effect similar to
that of atropine, sympathomimetic effect potentiating the
pressor effect of adrenaline, depolarising effect at the neuro-
muscular junction and direct influence on synaptic trans-
mission by mechanisms that are not clear at present (Bosˇ-
kovic´ & Stern 1963; Clement 1981; Busker et al. 1991; Mel-
chers et al. 1991; Van Helden et al. 1991 & 1996; Becker et
al. 1997). However, some failures of the standard therapy in
organophosphate poisoning are due to the unequal effec-
tiveness of oximes in the treatment of intoxications caused
by different organophosphorus compounds (Bismuth et al.
1992; Dawson 1994; Thiermann et al. 1999; Worek et al.
1996, 1997, 1998, 1999, 2002 & 2004). Many in vitro and in
vivo studies have been focused on the efficacy of the oximes
in organophosphate poisoning. Although some of them
were very difficult to interpret due to the differences in ex-
perimental design, it could be summarised that trimedoxime
(TMB-4) and obidoxime (LüH-6) were superior to the other
oximes used in organophosphorus insecticide poisoning
(Sanderson & Edson 1959; Jokanovic´ & Maksimovic´ 1995;
Worek et al. 1996, 1997 & 1999). It is also well known that
TMB-4 and LüH-6 (differing only in the structure of the
bridge between the two pyridinium rings) have a great react-
ivating potential, which explains their antidotal efficacy
against a number of organophosphorus insecticides (Hob-
biger & Vojvodic´ 1966; De Jong et al. 1982; Worek et al.
1996). Generally, the antidotal effect is highly dependent on
the type of the anticholinesterase and the oxime used.
Concerning all these data on oxime efficacy, the aim of
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the present study was (1) to examine and compare antidotal
potency of TMB-4 in mice poisoned with three direct dime-
thoxy-substituted inhibitors: dichlorvos, heptenophos and
monocrotophos, and (2) to correlate the protective efficacy
and reactivating ability of TMB-4 in central and peripheral
tissues of experimental animals.
Materials and Methods
Experimental animals. Male albino mice (18–24 g) were obtained
from the Military Medical Academy, Belgrade. The animals were
rested at least one week before the experiment and received food
and tap water ad libitum.
The study protocol was based on the Guidelines for Animal
Study no. 282-12/2002 (Ethics Committee of the Military Medical
Academy, Belgrade, Serbia and Montenegro).
Chemicals. Trimedoxime (1,1ø-trimethylene bis(4-hydroxyimino
methyl) pyridinium dichloride), was obtained from the Military
Medical Academy, Belgrade and was 99% pure when examined by
HPLC. Dichlorvos (2,2-dichlorovinyldimethylphosphate) (94.0%),
heptenophos ((7-chlorobicyclo[3.2.0]hepta-2,6-dien-6-yl)dimethyl-
phosphate) (92.0%) and monocrotophos (O,O-dimethyl-O-(1-
methyl-2-methyl-carbamoylvinyl) phosphate) (82.8%) were pur-
chased from the domestic commercial sources. Structural formulae
are presented in fig. 1.
Stock solutions of organophosphates were prepared in isopro-
panol. Oxime was dissolved in distilled water and diluted to the
required concentration immediately before use. All the solutions
were administered intravenously via the tail vein at a volume of 0.1
ml/20 g of body mass.
Experimental procedures.
Protection. In the studies of antidotal protection, experimental ani-
mals were pretreated intravenously with increasing doses of TMB-
4 at different time intervals (5–60 min.) before 1.3 LD50 intra-
venously of organophosphates. Median lethal doses of the tested
compounds (LD50) and median effective doses of oxime (ED50t)
were calculated according to the method of Litchfield & Wilcoxon
(1949), with 95% confidence limits. Median effective doses of the
oxime along with the corresponding time intervals were used to cal-
culate ED50 at null time (ED500) and efficacy half-time (t1/2 effi-
cacy) (Schoene et al. 1988).
Biochemistry. In the biochemical experiments, the brain, dia-
phragmal and erythrocyte AChE as well as plasma carboxylesterase
activities were determined. TMB-4 (24 mg/kg; 0.3 LD50 intra-
venously) was injected 5 min. before 1.3 LD50 intravenously of
poisons. Mice were decapitated and exsanguinated at different time
intervals (10, 40 and 60 min.) after the antidote administration.
Diaphragms and brains were removed and homogenised in isotonic
saline. The brain and diaphragmal enzyme activities were measured
by the spectrophotometric method (Ellman et al. 1961; Wilhelm
1968) using acetylcholine iodide as substrate. Erythrocyte AChE
activity was determined titrimetrically (Augustinsson 1971), while
acetylthiocholine iodide was added as substrate. Plasma carboxyles-
terase activity was assayed by the titrimetric pH-stat method (Clem-
ent 1982) using tributyrin (glycerin tributyrate) as a substrate. In
order to determine the enzyme activities in animals treated with
organophosphate alone (1.3 LD50 intravenously) (organophos-
phate control groups) and keep them alive until sacrifice, atropine
10 mg/kg intravenously had to be injected immediately before the
poisons.
Data analyses. Twenty-four-hr LD50 and ED50t of investigated
compounds (tables 1 & 2) were calculated by probit analysis accord-
ing to the method of Litchfield & Wilcoxon (1949).
Protective effect of TMB-4 based on ED500 and t1/2 efficacy
Table 1.
Intravenous median lethal doses of TMB-4 and organophosphorus
compounds.






in mice treated with organophosphorus compounds (table 2) was
calculated by means of 2¿2 assay (Pharm-Pharmacological Calcu-
lation System, v.4.0, Springer-Verlag, New York, USA, 1986).
Statistical significance between groups was determined by Mann-
Whitney U-test (fig. 2) and Student’s t-test (fig. 3, 4 & 5). The differ-
ences were considered significant when P value was less than 0.05.
Statistical analyses were performed with commercial statistical soft-
ware for PC, Stat for Windows R. 5.0.
Results
Intravenous LD50s of investigated compounds are given in
table 1. It is evident that LD50 of heptenophos is about
10 times higher than in the other two organophosphorus
compounds tested. This finding should be ascribed to com-
plex interactions of numerous factors such as electronic ef-
fects, hydrophobicity, steric effects, ionic bonds, toxicoki-
netic properties and non-anticholinesterase effects (Max-
well & Lenz 1992).
Toxicity signs were typical of cholinesterase inhibition.
Time to their onset was short and death usually occurred
within 5–10 min. after administration of a lethal dose. This
very short survival of mice that were not pretreated with
TMB-4 imposed use of an experimental model based on
administration of the oxime at various times before intra-
venous injection of organophosphorus compounds.
Use of TMB-4 against monocrotophos protected success-
Table 2.
Protective effects of TMB-4 in mice treated by 1.3 LD50 intra-
venously of organophosphorus compounds.
ED50t, mmol/kg (95% confidence interval)Time
(min.) Monocrotophos Dichlorvos Heptenophos
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fully the experimental animals along the whole time interval
tested. The dose (ED500) of TMB-4 necessary to protect
50% of animals after the simultaneous administration of
monocrotophos and oxime was 21.6 and 7.5 times lower
than the corresponding doses calculated for the protocols
with dichlorvos and heptenophos, respectively. Addition-
ally, half-time of efficacy in monocrotophos poisoning was
longer than in the case of dichlorvos or heptenophos intoxi-
cation indicated that TMB-4 was the most effective in pro-
tection against monocrotophos (table 2). ED500 of the oxi-
me obtained in heptenophos poisoning was about 2.9 times
lower than in experiments where dichlorvos was applied.
However, half-time of efficacy in heptenophos poisoning
was almost two times shorter than in the case of dichlorvos-
treated animals. Therefore, considering both parameters it
seemed that TMB-4 was more effective in protection against
heptenophos.
Biochemical results showed that mice that received only
dichlorvos had no detectable erythrocyte AChE activity (fig.
2). However, in mice pretreated with TMB-4, the level of
erythrocyte AChE recovered gradually over a 60 min. time
Fig. 1. Structural formulae of oxime and organophosphorus compounds.
period up to 92.00% of the total activity. After administra-
tion of dichlorvos, mice still had 8.3% of their brain and
35.10% of diaphragmal AChE functional. In the presence
of TMB-4, AChE activity increased in both tissues, reaching
its maximal level within 40 min., i.e. 37.80% and 85.63% of
total brain and diaphragmal AChE activity, respectively
(fig. 3 & 4).
After heptenophos intoxication, some tissue AChE activ-
ity (3.33% in erythrocytes, 3.37% in brain and 13.05% in
diaphragm) remained uninhibited. After the 40 min. time
interval, mice that received TMB-4 pretreatment still had
no detectable erythrocyte AChE activity. However, erythro-
cyte AChE activity, measured at 60 min. after antidotal
treatment, was about 10.67% of the control activity (fig. 2).
One hour after administration of TMB-4, AChE activity
recovered to 29.43% and 69.57% of the control brain and
diaphragmal AChE activity, respectively (fig. 3 & 4). Unex-
pectedly, TMB-4 was not successful in restoring the AChE
inhibited by monocrotophos (fig. 2, 3 & 4).
All the organophosphorus compounds tested produced
significant inhibition of carboxylesterase activity in plasma.
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Fig. 2. The effect of TMB-4 on erythrocyte AChE activity in mice
poisoned with 1.3 LD50 intravenously of dichlorvos (D), hepten-
ophos (H) or monocrotophos (M). Data are means∫S.D. of nine
animals. c – P∞0.001 versus poisoned group. aø,bø – P∞0.05, 0.01.
When the oxime was administered to the animals poisoned
with dichlorvos, heptenophos or monocrotophos, carboxy-
lesterase activity recovered to its maximum of 37.23%,
75.62% and 54.28% of the control activity, respectively (fig.
5).
Discussion
Trimedoxime is already well known as a potent reactivator
of diethoxy, ethylethoxy-, methylethoxy-, methylisopropoxy-
or diisopopoxy-phosphorylated cholinesterase (Reiner
1965; Dirks et al. 1970; Schoene & Strake 1971; Patocˇka
1973). Hobbiger & Sadler (1958) showed that TMB-4 was
a significantly better reactivator than a pralidoxime
methyliodide in mice poisoned with phospholine. In 1966,
Hobbiger & Vojvodic´ showed that TMB-4 was a better re-
activator of diethyl- and diisopropyl-phosphorylated acetyl-
cholinesterase of human erythrocytes than LüH-6. Similar
results were obtained by Bajgar et al. (1971) in experiments
with equimolar doses of these two bispyridinium dioximes.
In the experiments of Jokanovic´ & Maksimovic´ (1995),
where pyridinium oximes (pralidoxime, TMB-4, LüH-6, HI-
6) were administered along with atropine and diazepam to
rats poisoned with 2 LD50 of organophosphorus insecti-
cides including dichlorvos, heptenophos and monocro-
tophos, better protection was achieved when TMB-4 and
LüH-6 were used. All these data clearly indicate that TMB-
4 or LüH-6 can be accepted as the oximes of choice against
the majority of organophosphorus insecticide poisonings.
In our experiment, along the investigated time interval,
protective effect of TMB-4 decreased according to the fol-
lowing order: monocrotophos  heptenophos  dichlorvos
(table 2). Administration of trimedoxime produced a sig-
nificant reactivation of central and peripheral AChE inhib-
ited with dichlorvos and heptenophos, with the exception
of erythrocyte AChE inhibited by heptenophos (fig. 2, 3 &
4). Surprisingly, although TMB-4 was the most effective in
protection of monocrotophos-poisoned mice, it did not in-
duce reactivation of inhibited AChE in any of the tissues
Fig. 3. The effect of TMB-4 on brain AChE activity in mice poison-
ed with 1.3 LD50 intravenously of dichlorvos (D), heptenophos (H)
or monocrotophos (M). Data are means∫S.D. of nine animals.
a, c – P∞0.05, 0.001 versus poisoned group. aø, bø – P∞0.05, 0.01.
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Fig. 4. The effect of TMB-4 on diaphragmal AChE activity in mice
poisoned with 1.3 LD50 intravenously of dichlorvos (D), hepten-
ophos (H) or monocrotophos (M). Data are means∫S.D. of nine
animals. a, b – P∞0.05, 0.01 versus poisoned group. aø, bø – P∞0.05,
0.01.
tested. These conflicting results were probably due to the
production of monocrotophos metabolites (N-methylhy-
droxy monocrotophos and N-desmethyl monocrotophos),
known as analogues, the toxicities of which are comparable
to the parent compound (Menzer & Casida 1965; Skrip-
sky & Loosli 1994). Such biotransformation of monocro-
tophos probably led to a fast reinhibition of the previously
reactivated AChE. Thiermann et al. (1997) had shown that
a significant reactivation occurred only after the organ-
ophosphorus concentration in the body fell below a critical
value, i.e. significant reactivation occurred only when the
reactivation rate exceeded the inhibition rate. Another in-
teresting feature was that the animals treated with TMB-4
were alive during the 60 min. time period albeit correspond-
ing AChE activities did not differ significantly from the
group which received monocrotophos only. The observed
discrepancy indicated that TMB-4 had a therapeutic action
independent of AChE-reactivation. One could conclude
that the so called ‘‘direct’’ effects of TMB-4, i.e. pharmaco-
logical effects other than reactivation of AChE were essen-
tial for the survival of monocrotophos-intoxicated mice.
The beneficial effects of oximes are generally thought to
be due to their ability to reactivate the inhibited enzyme,
although the protective effect is attributed at least partly to
action(s) other than enzyme reactivation. Therefore, contri-
bution of pharmacological effects other than reactivation
of AChE, including the direct interaction between the oxime
and the active site of AChE, should not be excluded. Il-
lustrative to this notion are several findings where HI-6 an-
tagonised lethal soman poisoning of primates although ac-
tivity of blood AChE was very low (Lipp & Dola 1980;
Hamilton & Lundy 1989; Van Helden et al. 1992). It is well
known from the literature that TMB-4 acts as weak AChE
inhibitor (Bismuth et al. 1992). In our experiment the de-
gree of AChE inhibition induced by TMB-4 should not dif-
fer among the mice subsequently poisoned with dichlorvos,
monocrotophos or heptenophos. Despite the fact that the
experimental design used could not differentiate between
Fig. 5. The effect of TMB-4 on plasma carboxylesterase (CarbE)
activity in mice poisoned with 1.3 LD50 intravenously of dichlorvos
(D), heptenophos (H) or monocrotophos (M). Data are
means∫S.D. of nine animals. a, b, c – P∞0.05, 0.01, 0.001 versus
poisoned group. bø, cø – P∞0.01, 0.001.
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the protection and reactivation of AChE it is reasonable to
assume that the reactivating mechanism accounts for the
major part of the overall protection obtained. On the other
hand, it is well known that TMB-4 possesses curare- and
atropine-like effects and exerts hypotension in experimental
animals. Hobbiger & Sadler (1959) showed that TMB-4 re-
duced sensitivity of small intestine to acetylcholine in
guinea pigs while Bosˇkovic´ & Stern (1963) proved its direct
effect on the activity of the rat striated muscle. Results of
Lindgren & Sundwall (1960) confirmed its strong parasym-
patholytic effect in animals not exposed to organophos-
phates.
The phosphorylation occurs by the loss of the ‘‘leaving
group’’ of the organophosphorus compound and the for-
mation of a covalent bond with AChE through the serine
hydroxyl group. Differing only in their leaving groups,
dichlorvos, heptenophos and monocrotophos generate the
same type, i.e. dimethoxy-phosphorylated AChE. Interest-
ingly, the extent of its reactivation was not equal. A similar
finding was obtained in in vitro experiment where mev-
inphos, malaoxon and trichlorfon were used as inhibitors
of human erythrocyte AChE by Worek et al. (1997), con-
firming that the contribution of a specific ‘‘leaving group’’
to the complexity of toxic response to organophosphates
should be taken into account in attempt to assess the anti-
dotal efficacy.
Dichlorvos, heptenophos and monocrotophos induced
statistically significant inhibition of plasma carboxylesterase
activity, while the administration of TMB-4 led to its sig-
nificant reactivation (fig. 5). It is well known that carboxyle-
sterase detoxify organophosphorus compounds so that they
are considered a protective buffer for AChE. Regeneration
of carboxylesterase produced by TMB-4 seems to be im-
portant additional mechanism contributing to its antidotal
effects.
The reactivity of organophosphorus compounds varies
depending upon their chemical structure. The organ-
ophosphorus pesticides or their active metabolites are elec-
trophilic compounds with moderate to high potency for
phosphorylating the serine hydroxyl group located at the
active site of AChE. The same dose of TMB-4 kept experi-
mental animals alive in poisonings caused by all three or-
ganophosphorus compounds, but at the same time bio-
chemical findings were quite different. It was very difficult
or even impossible to correlate protective effect of the oxime
with its ability to reactivate the inhibited acetylcholine-
sterase. With the presumption that pharmacokinetic prop-
erties of TMB-4 (Milic´ et al. 1996) were not affected sig-
nificantly by the tested organophosphates, as shown pre-
viously in experiments with HI-6 and HLö-7 (Go¨ransson-
Nyberg et al. 1995; Worek et al. 1995), the antidotal efficacy
of TMB-4 was predominantly under the influence of toxic-
odynamic and toxicokinetic characteristics of organophos-
phates used in this experiment (Jokanovic´ 2001; Karalliedde
et al. 2003). Having in mind numerous factors that influence
the antidotal potency of oximes, further investigations are
necessary in order to optimise the antidotal therapy. There-
fore, intentions aimed at synthesis an oxime with ‘‘univer-
sal’’ antidotal properties seem to be still a promising re-
search field.
Acknowledgements
This work was supported by grant 1432 from the Minis-
try of Science and Environmental Protection, Republic of
Serbia.
References
Augustinsson, K. B.: Determination of activity of cholinesterase.
In: Analysis of biogenic amines and their related enzymes. Ed.: D.
Glick. John Wiley & Sons, London, 1971, pp. 217–273.
Bajgar, J., A. Jakl & V. Hrdina: Influence of trimedoxime and atro-
pine on acetylcholinesterase activity in some parts of the brain
of mice poisoned by isopropylmethyl phosphonofluoridate. Bio-
chem. Pharmacol. 1971, 20, 3230–3233.
Becker, G., A. Kawan & L. Szinicz: Direct reaction of oximes with
sarin, soman, or tabun in vitro. Arch. Toxicol. 1997, 71, 714–718.
Bismuth, C., R. H. Inns & T. C. Marrs: Efficacy, toxicity and clinical
use of oximes in anticholinesterase poisoning. In: Clinical and
experimental toxicology of organophosphates and carbamates.
Eds.: B. Ballantyne & T. C. Marrs. Butterworth-Heinemann, Ox-
ford, 1992, pp. 555–577.
Bosˇkovic´, B. & P. Stern: Uticaj nekih reaktivatora ChE na aktivnost
poprecˇno-prugaste muskulature in vivo (m. masseter sˇtakora).
Arh. Hig. Rada. 1963, 14, 171–177.
Busker, R. W., J. J. Zijlstra, H. J. Van der Wiel, B. P. C. Melchers &
H. P. M. Van Helden: Organophosphate poisoning: a method to
test therapeutic effects of oximes other than acetylcholinesterase
reactivation in the rat. Toxicology 1991, 69, 331–344.
Clement, J. G.: Toxicology and pharmacology of bispyridinium ox-
imes – Insight into the mechanism of action vs soman poisoning
in vivo. Fund. Appl. Toxicol. 1981, 1, 193–202.
Clement, J. G.: Plasma aliesterase: a possible depot for soman (pin-
acolylmethylphosphonofluoridate) in the mouse. Biochem. Phar-
macol. 1982, 31, 4085–4088.
Dawson, R. M.: Review of oximes available for treatment of nerve
agent poisoning. J. Appl. Toxicol. 1994, 14, 317–331.
De Jong, L. P. A., G. Z. Wolring & H. P. Benschop: Reactivation
of anticholinesterase inhibited by methamidophos and analogous
(di)methylphosphoramidates. Archneimittelf. Toxicol. 1982, 49,
175–183.
Dirks, E., A. Scherer, M. Schmidt & G. Zimmer: Beziehungen
zwischen chemischer Struktur und cholinesterase-reaktivieren der
Wirkung bei einer Reihe neuer unsymmetrischer Pyridiniumsalze.
Arzneim. Forsch. 1970, 20, 55.
Ellman, G. L., K. D. Curtney, V. Andres & R. M. Featherstone: A
new and rapid colorimetric determination of acetylcholinesterase
activity. Biochem. Pharmacol. 1961, 7, 88–95.
Go¨ransson-Nyberg, A., G. Cassel, T. Jeneskog, L. Karlsson, R.
Larsson, M. Lundstro¨m & S. A. Persson: Treatment of organo-
phosphate poisoning in pigs: antidote administration by a new
binary autoinjector. Arch. Toxicol. 1995, 70, 20–27.
Hamilton, M. & P. M. Lundy: HI-6 therapy of soman and tabun
poisoning in primates and rodents. Arch. Toxicol. 1989, 63, 144–
149.
Hobbiger, F. & P. W. Sadler: Protection by oximes of bis-pyridinium
ions against lethal diisopropyl phosphonofluoridate poisoning.
Nature 1958, 182, 1672.
Hobbiger, F. & P. W. Sadler: Protection against lethal organophos-
phate poisoning by quaternary pyridine aldoximes. Brit. J. Phar-
macol. 1959, 14, 190–201.
Hobbiger, F. & V. Vojvodic´: The reactivating and antidotal actions
of N,Nø-trimethylenebis(pyridinium-4-aldoxime) (TMB-4) and
117EFFICACY OF TRIMEDOXIME IN ORGANOPHOSPHATE POISONING
N,Nø-oxydimethylenebis (pyridinium-4-aldoxime) (toxogonin),
with particularly reference to their effect on phosphorylated ace-
tylcholinesterase in the brain. Biochem. Pharmacol. 1966, 15,
1677–1690.
Jokanovic´, M.: Biotransformation of organophosphorus com-
pounds. Toxicology 2001, 166, 139–160.
Jokanovic´, M. & M. Maksimovic´: A comparison of trimedoxime,
obidoxime, pralidoxime and HI-6 in the treatment of oral organ-
ophosphorus insecticide poisoning in the rat. Arch. Toxicol.
1995, 70, 119–123.
Jokanovic´, M., M. Kosanovic´ & M. Maksimovic´: Interaction of
organophosphorus compounds with carboxylesterases in the rat.
Arch. Toxicol. 1996, 70, 444–450.
Karalliedde, L. & L. Szinicz: Management of organophosphorus
compound poisoning. In: Organophosphates and health. Ed.: L.
Karalliedde, S. Feldman, J. Henry & T. Marrs. Imperial College
Press, London, 2001, pp. 257–94.
Karalliedde, L.D., P. Edwards & T. C. Marrs: Variables influencing
the toxic response to organophosphates in humans. Food. Chem.
Toxicol. 2003, 41, 1–13.
Koelle, G. B.: Anticholinesterase agents. In: The pharmacological
basis of therapeutics. Eds.: L. S. Goodmann, A. Gilman, A. G.
Gilman & G. B. Koelle. Macmillan, New York, 1975, pp. 445–
466.
Lindgren, P. & A. Sundwall: Parasympatholytic effects of TMB-4
[1,1-trimethylene-bis(4-formylpyridinium bromide)-dioxime] and
some related oximes in cat. Acta pharmacol. et toxicol. 1960, 17,
69–83.
Lipp, J. & T. Dola: Comparison of the efficacy of HS-6 versus HI-
6 when combined with atropine, pyridostigmine and clonazepam
for soman poisoning in the monkey. Arch. Int. Pharmacodyn.
Ther. 1980, 246, 138–148.
Litchfield, J. T. & F. Wilcoxon: A simplified method of evaluating
dose-effect experiments. J. Pharmacol. Exp. Therap. 1949, 96,
99–113.
Maxwell, D. M. & D. E. Lenz: Structure-activity relationships and
anticholinesterase activity. In: Clinical and experimental toxi-
cology of organophosphates and carbamates. Eds.: B. Ballan-
tyne & T. C. Marrs. Butterworth-Heinemann, Oxford, 1992, pp.
47–58.
Melchers, B. P. C., A. L. Van der Laaken & H. P. M. Van Helden:
On the mechanism whereby HI-6 improves neuromuscular func-
tion after oxime-resistant acetylcholinesterase inhibition and sub-
sequent impairment of neuromuscular transmission. Eur. J.
Pharmacol. 1991, 200, 331–337.
Menzer, R. L. & J. E. Casida: Nature of toxic metabolites formed in
mammals, insects and plants from 3-(dimethoxy phosphinyloxy)-
N,N-dimethyl-cis-crotonamide and its N-methyl analog. J. Agr.
Fd. Chem. 1965, 13, 102–112.
Milic´, B., M. Maksimovic´ & M. Nedeljkovic´: Trimedoxime and HI-
6: Kinetic comparison after intravenous administration to mice.
Pharmacology & Toxicology 1996, 78, 269–272.
Patocˇka, J.: Equilibrium kinetics of reactivation of phosphonylated
acetylcholinesterase by oximes. Collection. Czechoslov. Chem.
Commun. 1973, 38, 1996–3003.
Reiner, E.: Oxime reactivation of erythrocyte cholinesterase inhib-
ited by ethyl p-nitrophenyl ethylphosphonate. Biochem. J. 1965,
97, 710–714.
Sanderson, D. M. & E. F. Edson: Oxime therapy in poisoning by
six organophosphorus insecticides in the rat. J. Pharm. Pharmac-
ol. 1959, 11, 721–728.
Schoene, K. & E. M. Strake: Reaktivierung von diethylphosphoryl-
acetylcholinesterase. Biochem. Pharmacol. 1971, 20, 1041–1051.
Schoene, K., A. König, H. Oldiges & M. Krügel: Pharmacokinetics
and efficacies of obidoxime and atropine in paraoxon poisoning.
Arch. Toxicol. 1988, 61, 387–391.
Skripsky, T. & R. Loosli: Toxicology of monocrotophos. Rev. En-
viron. Contam. Toxicol. 1994, 139, 13–39.
Sogorb, M. A. & E. Vilanova: Enzymes involved in the detoxifica-
tion of organophosphorus, carbamate and pyrethroid insecticides
through hydrolysis. Toxicol. Lett. 2002, 128, 215–228.
Thiermann, H., U. Mast, R. Klimmek, P. Eyer, A. Hilber, R. Pfab,
N. Felgenhauer & T. Zilker: Cholinesterase status, pharmaco-
kinetics and laboratory findings during obidoxime therapy in or-
ganophosphate poisoned patients. Hum. Exp. Toxicol. 1997, 16,
473–480.
Thiermann, H., L. Szinicz, F. Eyer, F. Worek, P. Eyer, N. Felgenhau-
er & T. Zilker: Modern strategies in therapy of organophosphate
poisoning. Toxicol. Lett. 1999, 107, 233–239.
Van Helden, H. P. M., R. W. Busker, B. P. C. Melchers & P. L. B.
Bruijnzeel: Pharmacological effects of oximes: how relevant are
they. Arch. Toxicol. 1996, 70, 779–786.
Van Helden, H. P. M., J. De Lange, R. W. Busker & B. P. C. Melch-
ers: Therapy of organophosphate poisoning in the rat by direct
effects of oximes unrelated to ChE reactivation. Arch. Toxicol.
1991, 65, 586–593.
Van Helden, H. P. M., H. H. J. Van der Wiel, J. De Lange, R. W.
Busker, B. P. C. Melchers & O. L. Wolthuis: Therapeutic efficacy
of HI-6 in soman-poisoned marmoset monkeys. Toxicol. Appl.
Pharmacol. 1992, 115, 50–56.
Wilhelm, K.: Determination of human plasma cholinesterase activ-
ity by adapted Ellman’s method. Arh. Hig. Rada. Toksikol. 1968,
19, 199–207.
Worek, F., M. Bäcker, H. Thiermann, L. Szinicz, U. Mast, R. Klim-
mek & P. Eyer: Reappraisal of indications and limitations of oxi-
me therapy in organophosphate poisoning. Hum. Exp. Toxicol.
1997, 16, 466–472.
Worek, F., C. Diepold & P. Eyer: Dimethylphosphoryl-inhibited hu-
man cholinesterases: inhibition, reactivation, and aging kinetics.
Arch. Toxicol. 1999, 73, 7–14.
Worek, F., T. Kirchner, M. Bäcker & L. Szinicz: Reactivation by
various oximes of human erythrocyte acetylcholinesterase inhib-
ited by different organophosphorus compounds. Arch. Toxicol.
1996, 70, 497–503.
Worek, F., R. Klimmek & L. Szinicz: Effects of atropine and soman
on the pharmacokinetics of the oxime HLö7 dimethanesulfonate
in anesthetized guinea-pigs. Drug. Chem. Toxicol. 1995, 18, 137–
149.
Worek, F., G. Reiter, P. Eyer & L. Szinicz: Reactivation kinetics of
acetylcholinesterase from different species inhibited by highly
toxic organophosphates. Arch. Toxicol. 2002, 76, 523–529.
Worek, F., H. Thiermann & L. Szinicz: Reactivation and aging kin-
etics of human acetylcholinesterase inhibited by organophos-
phonylcholines. Arch. Toxicol. 2004, 78, 212–217.
Worek, F., R. Widmann, O. Knopff & L. Szinicz: Reactivating po-
tency of obidoxime, pralidoxime, HI-6 and HLö7 in human
erythrocyte acetylcholinesterase inhibited by highly toxic organ-
ophosphorus compounds. Arch. Toxicol. 1998, 72, 237–243.
